Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies
J. Gallaher, P. M. Enriquez-Navas, K. A. Luddy, R. A. Gatenby, and A. R. A. Anderson
Comparing continuous treatment (CT), adaptive therapy emphasizing dose modulation (AT1), & adaptive therapy emphasizing treatment vacations (AT2)